Inventor
STENNE BRICE
US8 patents
Patents
8 patentsUS10071988B2Sep 11, 2018
Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
JANSSEN PHARMACEUTICA NV17 citations93
US10233173B2Mar 19, 2019
Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
JANSSEN PHARMACEUTICA NV13 citations83
US10766880B2Sep 8, 2020
Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
JANSSEN PHARMACEUTICA NV2 citations72
US11447503B2Sep 20, 2022
Pyridine carbamates and their use as GLUN2B receptor modulators
JANSSEN PHARMACEUTICA NV2 citations70
US11530210B2Dec 20, 2022
Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators
JANSSEN PHARMACEUTICA NV2 citations68
US11161846B2Nov 2, 2021
Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators
JANSSEN PHARMACEUTICA NV2 citations67
US12172997B2Dec 24, 2024
Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators
JANSSEN PHARMACEUTICA NV0 citations48
US11618750B2Apr 4, 2023
Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators
JANSSEN PHARMACEUTICA NV0 citations48